AeroLeads people directory · profile
Darlene Deptula-Hicks Email & Phone Number
Interim Chief Financial Officer
at
Normunity
1 work email found
@f-star.com
4 phones found area 781, 978, and 573
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Interim Chief Financial Officer
Location
Greater Boston, United States, United States
Company size
Who is Darlene Deptula-Hicks? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Darlene Deptula-Hicks is listed as Interim Chief Financial Officer at Normunity, a company with 24 employees, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at f-star.com, phone signal with area code 781, 978, 573, and a matched LinkedIn profile for Darlene Deptula-Hicks.
Darlene Deptula-Hicks previously worked as Chief Financial Officer at Greywolf Therapeutics and Board Member at Avacta. Darlene Deptula-Hicks holds Executive Education Program from The Tuck School Of Business At Dartmouth.
Company email context
Email format at Normunity
This section adds company-level context without repeating Darlene Deptula-Hicks's masked contact details.
*@f-star.com
68% confidence
AeroLeads found 1 current-domain work email signal for Darlene Deptula-Hicks. Compare company email patterns before reaching out.
Profile bio
About Darlene Deptula-Hicks
A strategic and entrepreneurial business leader with extensive biotech, pharmaceutical, therapeutics, medical device, AI and diagnostics industry experience. Demonstrated ability to build, motivate, and manage cross-functional teams and build strong external partnerships to achieve business results and increase shareholder value. Extensive buy and sell side investor relations experience with longstanding track record of raising capital in both public and private equity markets and IPO experience. In addition to leadership and responsibility as CFO for finance, accounting, SEC reporting, Nasdaq and SOX compliance, M&A, investor relations, IT, treasury, tax, legal and HR activities also strong operational and commercial experience with in-depth understanding of product commercialization, supply chain, manufacturing and quality, product development, clinical and regulatory, BD and licensing. Board member and Audit Committee Chair since 2006. Public & Private Company Expertise: Pre-IPO/IPO/post-IPO deal experience with deep industry knowledge across life sciences with strong capital markets experience. Expertise in both public and private companies, from VC start-ups to mid-size companies and expertise with all GAAP, SEC reporting, Nasdaq, IFRS and SOX compliance and knowledge of complex revenue recognition. Capital Raising & Investor Relations: Longstanding track record of raising capital in public and private equity markets including IPO’s, secondary/follow-on public offerings, private equity, debt and venture financings of over $350M. Strong investment banker, analyst and investor contacts, and investor presentation skills. Serve as a key interface to the capital markets. Growth Strategies & M&A: Strong background in M&A transactions and roll-up strategies including, identify acquisition targets and leading M&A negotiations to completion and integration, licensing agreements and collaborations, and sell side transactions.
Listed skills include Revenue Recognition, Mergers, Medical Devices, Venture Capital, and 46 others.
Current workplace
Darlene Deptula-Hicks's current company
Company context helps verify the profile and gives searchers a useful next step.
Normunity
17 roles · 28 years
Darlene Deptula-Hicks work experience
A career timeline built from the work history available for this profile.
Chief Financial Officer
Current
Jul 2024 - Present
Jun 2024 - Present
Board Member And Audit Committee Chair
Current
Aerami Therapeutics
Oct 2021 - Present
Board Member & Audit Committee Chair
CurrentAbcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1.
Jul 2021 - Present
Chief Financial Officer/Business Owner
Current
Crimson Consulting, Llc
Greywolf Therapeutics - Chief Financial Officer - current Normunity Inc. - Acting Chief Financial Officer - currentAerami Therapeutics - Board Member, Audit Committee ChairF-Star Therapeutics, Inc., (NASDAQ:FSTX) Chief Financial Officer Northern Biologics, Inc. - Chief Financial Officer CannaKorp, Inc. - Chief Financial OfficerProviding strategic and.
Jan 2018 - Present
May 2019 - Mar 2023
Member Board Of Directors
Giner Life Sciences applies its world class technologies in electrochemical oxygenation to medical and life science applications with a focus on its miniature oxygen generation devices for implantable and wearable applications.
Apr 2019 - Sep 2021
Svp And Chief Financial Officer
T2 Biosystems (NASDAQ:TTOO) is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis, one of the most deadly and expensive conditions in hospitals today, and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics.
May 2017 - Jan 2018
Board Member And Audit Committee Chair
Xenetic Biosciences (NASDAQ:XBIO) is a biopharmaceutical company developing next generation biologic drugs and novel oncology therapeutics.
Apr 2014 - Aug 2017
Sr. Vice President & Chief Financal Officer
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) is a clinical-stage biotechnology company advancing its proprietary Anticalin® technology to create differentiated drugs that have the potential to be safer and more effective than conventional approaches. Anticalins show promise in addressing high-unmet medical needs and expanding the potential of targeted.
Dec 2014 - Feb 2017
Acting Cfo & Consultant
Several Companies
Providing strategic and operational consulting to biotech and medical device companies on an acting/interim CFO or consulting basis. Current engagements include:Pieris Pharmaceutical Corp. (OTC:PIRS) – Acting CFO for this clinical-stage biotechnology company through a reverse merger into a public shell with a pipe financing, and its subsequent operations.
Nov 2014 - Sep 2015
Vp And Chief Financial Officer
Microline Surgical, Inc. with offices in Boston, Amsterdam, Paris, Tokyo and Hong Kong is the leader in reposable surgical instruments offering a broad range of open and minimally invasive devices that offer high quality precision, combined with ease of use and cost effectiveness.
Jun 2012 - Nov 2014
Board Member & Audit Committee Chair
USF provides integrated technical solutions world wide to US government clients in national defense, security and intelligence.
2007 - 2014
~7 yrs
Executive Vice President And Chief Financial Officer
iCAD, Inc. (Nasdaq: ICAD) - An industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer.
2006 - 2011
~5 yrs
Executive Vice President And Chief Financial Officer
A mid stage, venture capital backed, designer and manufacturer of dedicated purpose, high field, diagnostic imaging systems for orthopedic and other applications.
2002 - 2006
~4 yrs
Vice President And Chief Financial Officer
Implant Science Corporation
A publicly traded (AMEX:IMX) designer and manufacturer of radiation oncology, interventional cardiology and orthopedic devices.
1998 - 2001
~3 yrs
3 education records
Darlene Deptula-Hicks education
Executive Education Program
The Tuck School Of Business At Dartmouth
Mba, Business
Rivier University
Bs, Accounting
Southern New Hampshire University
FAQ
Frequently asked questions about Darlene Deptula-Hicks
Quick answers generated from the profile data available on this page.
What company does Darlene Deptula-Hicks work for?
Darlene Deptula-Hicks works for Normunity.
What is Darlene Deptula-Hicks's role at Normunity?
Darlene Deptula-Hicks is listed as Interim Chief Financial Officer at Normunity.
What is Darlene Deptula-Hicks's email address?
AeroLeads has found 1 work email signal at @f-star.com for Darlene Deptula-Hicks at Normunity.
What is Darlene Deptula-Hicks's phone number?
AeroLeads has found 4 phone signal(s) with area code 781, 978, 573 for Darlene Deptula-Hicks at Normunity.
Where is Darlene Deptula-Hicks based?
Darlene Deptula-Hicks is based in Greater Boston, United States, United States while working with Normunity.
What companies has Darlene Deptula-Hicks worked for?
Darlene Deptula-Hicks has worked for Normunity, Greywolf Therapeutics, Avacta, Aerami Therapeutics, and Abcuro, Inc.
How can I contact Darlene Deptula-Hicks?
You can use AeroLeads to view verified contact signals for Darlene Deptula-Hicks at Normunity, including work email, phone, and LinkedIn data when available.
What schools did Darlene Deptula-Hicks attend?
Darlene Deptula-Hicks holds Executive Education Program from The Tuck School Of Business At Dartmouth.
What skills is Darlene Deptula-Hicks known for?
Darlene Deptula-Hicks is listed with skills including Revenue Recognition, Mergers, Medical Devices, Venture Capital, Ipo, Sec Filings, Strategy, and Risk Management.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial